FDA Approves FoundationOne Liquid CDx as Companion Diagnostic Test for Piqray Treatment
News
The U.S. Food and Drug Administration (FDA) has expanded the approval of Foundation Medicine’s FoundationOne Liquid CDx as a companion diagnostic test for identifying advanced or metastatic breast cancer patients suitable for treatment ... Read more